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Polymorphic variants of the P2X7 receptor in the domestic dog
Abstract
Due to distinctive features including genome architecture, population diversity, breed structure and breedspecific disorders, the domestic dog (Canis familiaris) is becoming an important animal to study the
genetics of morphology, behaviour and disease susceptibility in mammals [1]. Further, with around 360 of
the some 450 diseases in dogs similar to that of human diseases, dogs provide a valuable model to
identify the genetic causes of many diseases in humans [1]. Thus, one of the goals in canine biology is to
better define the genetic and phenotypic diversity that exists between the 400 dog breeds [2]. Therefore,
our groups have begun to explore the diversity in the gene encoding the canine P2X7 receptor (P2RX7)
and its impact on receptor function in this species [3], as well as the role of this receptor in dogs [4-8].
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Due to distinctive features including genome architecture,
population diversity, breed structure and breed-specific disorders, the domestic dog (Canis familiaris) is becoming an
important animal to study the genetics of morphology, behaviour and disease susceptibility in mammals [1]. Further,
with around 360 of the some 450 diseases in dogs similar
to that of human diseases, dogs provide a valuable model to
identify the genetic causes of many diseases in humans [1].
Thus, one of the goals in canine biology is to better define the
genetic and phenotypic diversity that exists between the 400
dog breeds [2]. Therefore, our groups have begun to explore
the diversity in the gene encoding the canine P2X7 receptor
(P2RX7) and its impact on receptor function in this species
[3], as well as the role of this receptor in dogs [4-8].
The P2X7 receptor is a trimeric ligand-gated cation channel,
which is activated by extracellular adenosine triphosphate
(ATP) and important in the release of pro-inflammatory mediators such as prostaglandins and cytokines of the interleukin-1 family [9]. As such, P2X7 has established roles in
inflammation, inflammatory disorders and pain [10]. In humans, the gene encoding P2X7 is highly polymorphic with at
least 15 non-synonymous (missense) single nucleotide polymorphisms (SNPs) encoding for receptors with either a loss
or gain of function [11]. Of note, a number of these SNPs are
associated with either increased susceptibility or resistance
to behavioural disorders, bone disease, infection, inflammatory disorders or pain [11].

The canine P2RX7 gene is located on chromosome 26, and

like its human orthologue, contains 13 exons [12]. Also similar to humans, the canine P2RX7 gene encodes a receptor
subunit 595 amino acid residues in length [3,13] with intracellular N- and C-termini, two trans-membrane domains
and an extracellular loop containing ATP binding sites [14].
In contrast to humans, the canine P2X7 subunit contains an
additional asparagine residue in the extracellular loop between positions 281 and 282, and lacks one residue in the
C-terminus [3,13] corresponding to Thr541 in the human
and mouse P2X7 subunits or Iso541 in the rat P2X7 subunit
[14] (Figure 1). The functional impacts of these two amino
acid differences have not been formally investigated. The additional asparagine residue lies within a key structural region of the extracellular loop, which interacts with the ATPbinding site and undergoes conformational changes during
receptor activation [14]. However canine P2X7 is functional
in dogs [4,6] and displays pharmacological properties similar to that of the human orthologue [8,13]. Thus, current evidence suggests that this additional asparagine residue has
little impact on receptor function. In contrast, the absence of
the isoleucine corresponding to residue 541 in rat receptors
most likely prevents the calcium-dependent facilitation of
canine P2X7-mediated currents. In rat P2X7, a 17 amino acid
sequence commencing at Iso541 forms a calmodulin-binding
motif, responsible for the calcium-dependent facilitation of
rat P2X7-mediated currents [15]. Importantly this isoleucine
residue is necessary for both the calcium-dependent facilitation of rat P2X7-induced currents and the binding of calmodulin to this receptor [15]. In contrast, neither of these events
occur with human P2X7, which contains Thr541 [16]. Collec-
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tively, this indicates that canine P2X7, which lacks Iso541, is
also unlikely to undergo significant calcium-dependent facilitation and to bind calmodulin. The physiological relevance
of the presence or absence of the calmodulin-binding motif
in mammalian P2X7 remains to be established.

Figure 1. The canine P2X7 receptor subunit. Triangles represent
additional (ins) or absent (del) amino acid residues in canine P2X7
compared to human (or rat) P2X7. Circles represent missense single nucleotide polymorphisms in canine P2X7 resulting in either
loss of function (red), possible gain (green) or partial loss (orange)
of function, or neutral effect on function (blue). Coloured lines represent a calcium-independent facilitation current motif (lime), a
pore sensibility and activation domain (purple), or a calmodulin
binding site (green) as previously described [20].

Recently our group cloned English Springer Spaniel P2X7,
and has assessed the functional impact of P2X7 variation in
a random sample of the canine population, which included
23 different breeds and a variety of cross breeds [3]. As a
result of this study, we identified three novel missense SNPs
(Arg270Cys, Arg365Gln and Leu440Phe) and confirmed the
presence of two previously reported missense SNPs (Phe103Leu, rs23314713; Pro452Ser, rs23315462) (Figure 1).
Of these five SNPs, the Arg270Cys SNP resulted in an almost
complete loss of receptor function despite normal surface
expression in cells. This SNP was found only in heterozygous
dosage with an allele frequency of 0.01, and appeared to be
associated with the Pro452Ser SNP and with Cocker Spaniels. Structural modeling of human P2X7 places Arg270 in
the lower body of the extracellular loop and away from the
ATP-binding site [14], but how the Arg270Cys SNP impairs
receptor function remains unknown. A partial loss of function SNP (Arg270His, rs7958311) is present in human P2X7
[17], indicating an important role for Arg270 in functional
P2X7 receptors. Of clinical relevance, the Arg270His SNP
is associated with reduced post-mastectomy pain in breast
cancer patients, as well as with reduced pain in patients with
osteoarthritis [18]. Thus, the Arg270Cys SNP may also be associated with reduced pain sensitivity in Cocker Spaniels or

2
other breeds possibly encoding this SNP.

Of the other canine P2X7 SNPs identified, the Phe103Leu
and Arg365Gln SNPs may be partial loss-of-function mutations. However the current body of evidence is limited as total P2X7 expression was also lower in the heterologous cell
assay used [3]. This may reflect either differences in transfection efficiency or real differences in protein expression.
The Phe103Leu SNP was frequently observed in dogs with
an allele frequency of 0.38 [3], and Phe103 is conserved in
human and rodent P2X7 suggesting that this residue is important in P2X7 function. Notably the first cloned canine
P2X7 (which contains Leu103) displays an agonist profile
[13] different to that of the cloned English Springer Spaniel
P2X7 (which contains Phe103) [3,8]. In these latter studies
ATP was shown to be a partial agonist of English Springer
Spaniel P2X7 compared to 2’(3’)-O-(4-benzoyl)benzoyl ATP
(BzATP) [3,8], while in the former study, BzATP was a partial agonist compared to ATP [13]. Given that residue 103
is in the extracellular loop of the P2X7 subunit, which contains the ATP binding sites, it is possible that this residue
contributes to ATP and BzATP sensitivity, and that the Phe103Leu SNP may modulate ATP binding in vivo. In contrast
to the high frequency of the Phe103Leu SNP, the Arg365Gln
SNP had an allele frequency of 0.03, was only found in heterozygous dosage, and appeared to be associated Labrador
Retrievers [3]. Arg365, which is conserved in the equivalent
positions in human and rodent P2X7, lies within a motif that
contributes to calcium-independent facilitation of P2X7-mediated currents [16], however the contribution of Arg365 to
this action remains unknown.
Evidence indicated the Leu440Phe SNP may cause a partial
gain of P2X7 function, but this SNP was only observed in the
cloned English Springer Spaniel P2X7 receptor [3]. Thus, it
remains uncertain if this variant is a mutation arising from
the cloning process, or a SNP present in this or possibly
some other breeds. However Leu440 is conserved in equivalent positions in human and rodent P2X7, and resides within
a regulatory region of P2X7 [19], termed the pore sensibility
and activation domain by others [20]. Thus, it remains possible that the residue at position 440 may partly modulate or
regulate P2X7 function.

In contrast to the other canine P2X7 SNPs, the Pro452Ser
SNP had a neutral effect on P2X7 function [3]. This SNP had
an allele frequency of 0.39 in our cohort and also resides
within the pore sensibility and activation domain. Further,
this SNP is (somewhat serendipitously) located at the equivalent position of a partial loss-of-function SNP (Pro451Leu)
in murine P2X7 [21]. The different impact of these SNPs on
canine and murine P2X7 function most likely reflects the differences in physical properties between serine and leucine
residues.
Recent findings therefore demonstrate the presence of at
least five missense SNPs in the canine P2RX7 gene, four of
which may alter function. Of these SNPs, the Arg270Cys SNP
is potentially the most important. This SNP caused an almost
complete loss of receptor function and a similar SNP (Ar-
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g270His) at the equivalent position in human P2X7 is associated with reduced pain sensitivity. Whether the Arg270Cys
SNP has an important pathophysiological role in dogs, such
as reduced pain sensitivity, remains to be established. Further, the other SNPs in the canine P2RX7 gene require further investigation before a conclusion can be made about
their impact on receptor function and any potential association with disorders in dogs. Nevertheless these recent findings provide a basis from which further investigations into
the role of P2X7 and its polymorphic variants in canine biology can be made.
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